Linnaeus Therapeutics, Inc.

Amendment

CIK: 0001752026·Biotechnology·DELAWARE·Filed: Mar 31, 2026

Total Offering

$10,000,000

Amount Sold

$4,892,000

Investors

26

First Sale

Feb 17, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Patrick Mooney	Related Person
James Demetriades	Related Person
Michael Poisel	Related Person
Chris Arendt	Related Person
Todd Thomson	Related Person
John Lepping	Related Person

Company

Linnaeus Therapeutics, Inc.

30 WASHINGTON AVENUE, SUITE F

HADDONFIELD, NJ, 08033

856-433-1500

SEC Filing

0001752026-26-000006

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.